BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Climb Bio\, Inc. readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Climb Bio\, Inc.'s drugs run\, fr
 om ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07043946-10939@assetmemo.bio
DTSTAMP:20261121T010137Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:budoprutug: Phase 1/2 readout est. (NCT07043946)
DESCRIPTION:budoprutug\, phase 1/2.\nStudy: A Phase 1b/2a Study of Budoprut
 ug in Subjects With Immune Thrombocytopenia (ITP)\nEstimated primary compl
 etion: August 2027. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/b
 udoprutug#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT07043946
URL:https://assetmemo.bio/drug/budoprutug#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07564596-10939@assetmemo.bio
DTSTAMP:20261121T010137Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:budoprutug: Phase 1/2 readout est. (NCT07564596)
DESCRIPTION:budoprutug\, phase 1/2\, Systemic Lupus Erythematosus.\nStudy: 
 A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)\nE
 stimated primary completion: September 2027. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/budoprutug#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07564596
URL:https://assetmemo.bio/drug/budoprutug#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07096843-10939@assetmemo.bio
DTSTAMP:20261121T010137Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:budoprutug: Phase 2 readout est. (NCT07096843)
DESCRIPTION:budoprutug\, phase 2\, Primary Membranous Nephropathy.\nStudy: 
 A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropa
 thy\nEstimated primary completion: October 2027. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/budoprutug#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT07096843
URL:https://assetmemo.bio/drug/budoprutug#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
